Login
$SUPN
$40.96 +$0.19 (0.47%) Close

$SUPN 3 SEC Filings

Filed On Filing
10 Mar 2026 Form 3: Horich William Todd, SVP, Commercial Operations

Holds 4,832 shares of Common Stock

21 Aug 2023 Form 3: Sensenig Bethany, Director

No securities owned

24 Aug 2021 Form 3: Dec Timothy C, Senior Vice-President & CFO

No securities owned

04 Jan 2021 Form 3: Rubin Jonathan, SVP, Chief Medical Officer
13 Oct 2020 Form 3: Kelly James Patrick, Executive Vice-President & CFO

No securities owned

25 Feb 2020 Form 3: Mottola Frank, Sr VP, Quality, GMP Oper. & IT

Holds 6,242 shares of Common Stock

25 Feb 2020 Form 3: Martin Tami Tillotson, Sr. V.P., Regulatory Affairs

Holds 85,279 shares of Common Stock

02 Jul 2018 Form 3: Barlow Carrolee, Director

No securities owned

23 Mar 2015 Form 3: Gemayel Georges, Director

No securities owned

24 Jan 2013 Form 3: Vaughn Victor, Senior Vice President of Sales

Holds 700 shares of Common Stock

07 Sep 2012 Form 3: Schwabe Stefan K.f., Executive Vice President R&D

No securities owned

30 Apr 2012 Form 3: Abingworth Management Ltd, 10% owner
30 Apr 2012 Form 3: Orbimed Advisors Llc, 10% owner and 2 others
30 Apr 2012 Form 3: Siebert John M, Director
30 Apr 2012 Form 3: Sheffery Michael B, Director
30 Apr 2012 Form 3: Patrick Gregory S, VP, Chief Financial Officer
30 Apr 2012 Form 3: Nuerge William A., Director

Holds 8,750 shares of Common Stock

30 Apr 2012 Form 3: Martin Tami Tillotson, VP of Regulatory Affairs
30 Apr 2012 Form 3: Khattar Jack A., Director

Holds 397,058 shares of Common Stock

30 Apr 2012 Form 3: Hudson Frederick M., Director

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support